A Commentary to “The prevalence of hypertensive diseases and treated hypertensive patients in Japan: a nationwide administrative claims database study”

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1274-1275
Number of pages2
JournalHypertension Research
Issue number8
Publication statusPublished - 2022 Aug

Bibliographical note

Funding Information:
SP does not have any direct conflict of interest with this study. However, SP has received honorarium from Pfizer, Beatrice, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, and Daewon. SP also has received research grant from Daiichi Sankyo.

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this